Effect of Imatinib on Bone Marrow Morphology and Angiogenesis in Chronic Myeloid Leukemia

BACKGROUND AND OBJECTIVES: Chronic myeloid leukemia (CML) is characterized by hyperproliferation of myeloid precursors, increased fibrosis, and neoangiogenesis in the bone marrow. Imatinib inhibits BCR-ABL tyrosine kinase produced due to reciprocal translocation t(9;22) in neoplastic CML cells. It r...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Adv Hematol
Hlavní autoři: Pandey, Neetu, Yadav, Geeta, Kushwaha, Rashmi, Verma, Shailendra Prasad, Singh, Uma Shankar, Kumar, Ashutosh, Mishra, Prabhaker
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi 2019
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6332991/
https://ncbi.nlm.nih.gov/pubmed/30713559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/1835091
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky